Media Delegation Visits WeMed To Explore Medical Technology Innovations

On September 19, a delegation from the China Medical News Information Association, together with leading media outlets, visited WeMed Medical to explore the forefront of medical technology. CEO of WeMed Medical, Mr. Yang He warmly welcomed President Shen Jingwang and the delegation. Focusing on the company's interventional surgical robot, Mr. Yang shared the inspiring story of China's self-reliant innovation and progress in high-end medical equipment.

A decade ago, WeMed Medical was like a young sapling in the Beijing Economic-Technological Development Area. Today, it has grown into a nationally recognized "Little Giant" specializing in innovative technologies, a National High-Tech Enterprise, and one of Beijing's first pilot enterprises for integrated industrial development. Its products are now exported to more than 40 countries and regions worldwide.

Upon entering the exhibition hall, visitors are guided through a "full interventional process" corridor showcasing groundbreaking technologies. These include:

• China's first DSA system with both NMPA and CE certifications, breaking the international brand monopoly, overcoming key technological bottlenecks, and filling the gap in the domestic high-end DSA market.
• An AI-powered imaging platform that leverages advanced high-definition algorithms to map blood vessels with exceptional clarity, enabling the detection of even the smallest lesions.
• Mobile C-arms that deliver precise orthopedic and gynecological imaging, enhancing the quality of emergency care.

A standout innovation is the interventional surgical robot-the first of its kind in China to be approved under the National Class III Medical Device Innovation Pathway. It seamlessly integrates multi-dimensional image fusion, dexterous robotic operation, intelligent decision-making, and surgical navigation. This synergy removes information barriers and enables highly precise, real-time diagnosis and treatment with outstanding collaborative capability.

This journey from follower to leader-supported by hundreds of patents and numerous national research projects-has transformed what was once considered impossible into a milestone in China's high-end medical history. The delegation witnessed not only WeMed's strength but also the determined rise of Chinese interventional device companies on the global stage. Moving forward, WeMed will continue to advance industry–academia–research–medicine collaboration, delivering every product as a true "Chinese solution" for life-saving care.